GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue
Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.
Read the full story at Bloomberg MarketsOpen in the live monitor